Mark Jacobs

819 total citations
10 papers, 506 citations indexed

About

Mark Jacobs is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Mark Jacobs has authored 10 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 4 papers in Microbiology and 3 papers in Infectious Diseases. Recurrent topics in Mark Jacobs's work include Reproductive tract infections research (4 papers), Urinary Tract Infections Management (2 papers) and HIV Research and Treatment (2 papers). Mark Jacobs is often cited by papers focused on Reproductive tract infections research (4 papers), Urinary Tract Infections Management (2 papers) and HIV Research and Treatment (2 papers). Mark Jacobs collaborates with scholars based in United States, Australia and Israel. Mark Jacobs's co-authors include Seng Jaw Soong, Michael L. Grossbard, Marc S. Ernstoff, Lynn E. S̄pitler, F. Ann Hayes, Amelia E. Pearsall, Kathryn Underwood, Yijun Yang, William G. Kramer and Matthew L. Sherman and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Mark Jacobs

10 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Jacobs United States	8	219	177	150	88	72	10	506
J M Trang United States	9	150 0.7×	146 0.8×	203 1.4×	69 0.8×	139 1.9×	12	719
Shuichiro Takashima Japan	9	171 0.8×	221 1.2×	204 1.4×	329 3.7×	57 0.8×	24	610
Akihiro Masuda Japan	10	135 0.6×	266 1.5×	55 0.4×	47 0.5×	68 0.9×	24	505
Takuya Matsumura Japan	14	134 0.6×	219 1.2×	177 1.2×	50 0.6×	237 3.3×	20	734
Rosealee Smith Australia	4	142 0.6×	355 2.0×	131 0.9×	64 0.7×	57 0.8×	4	530
Ketty Gianesin Italy	12	133 0.6×	106 0.6×	101 0.7×	42 0.5×	132 1.8×	18	431
Andrew J. Portuguese United States	10	126 0.6×	234 1.3×	151 1.0×	90 1.0×	54 0.8×	36	542
H. Makni Tunisia	14	57 0.3×	269 1.5×	82 0.5×	59 0.7×	109 1.5×	51	692
Alexander P. de Porto Netherlands	9	89 0.4×	102 0.6×	124 0.8×	43 0.5×	93 1.3×	12	478
Toshiro Kurokawa Japan	14	170 0.8×	253 1.4×	96 0.6×	180 2.0×	63 0.9×	31	550

Countries citing papers authored by Mark Jacobs

Since Specialization

Citations

This map shows the geographic impact of Mark Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Jacobs more than expected).

Fields of papers citing papers by Mark Jacobs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Jacobs. The network helps show where Mark Jacobs may publish in the future.

Co-authorship network of co-authors of Mark Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Jacobs. A scholar is included among the top collaborators of Mark Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Jacobs. Mark Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Mauck, Christine, Sharon L. Hillier, Hongsheng Wu, et al.. (2023). Acceptability of Single-dose Clindamycin Gel for Bacterial Vaginosis: A Randomized Controlled Trial. Clinical Therapeutics. 45(5). 415–425. 2 indexed citations

Mauck, Christine, et al.. (2022). Single-Dose, Bioadhesive Clindamycin 2% Gel for Bacterial Vaginosis. Obstetrics and Gynecology. 139(6). 1092–1102. 8 indexed citations

Schwebke, Jane R., Ryan Sobel, Janet Gersten, et al.. (2021). Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303). Clinical Infectious Diseases. 74(11). 1979–1985. 62 indexed citations

Chavoustie, Steven, Mark Jacobs, Arthur Waldbaum, et al.. (2014). Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis. Journal of Lower Genital Tract Disease. 19(2). 129–134. 18 indexed citations

Ruckle, Jon, Mark Jacobs, William G. Kramer, et al.. (2008). Single-Dose, Randomized, Double-Blind, Placebo-Controlled Study of ACE-011 (ActRIIA-IgG1) in Postmenopausal Women. Journal of Bone and Mineral Research. 24(4). 744–752. 171 indexed citations

Gewurz, Benjamin E., et al.. (2004). Capravirine, a Nonnucleoside Reverse‐Transcriptase Inhibitor in Patients Infected with HIV‐1: A Phase 1 Study. The Journal of Infectious Diseases. 190(11). 1957–1961. 12 indexed citations

Skowron, Gail, Gifford Leoung, David B. Hall, et al.. (2004). Pharmacokinetic Evaluation and Short-Term Activity of Stavudine, Nevirapine, and Nelfinavir Therapy in HIV-1???Infected Adults. JAIDS Journal of Acquired Immune Deficiency Syndromes. 35(4). 351–358. 10 indexed citations

S̄pitler, Lynn E., Michael L. Grossbard, Marc S. Ernstoff, et al.. (2000). Adjuvant Therapy of Stage III and IV Malignant Melanoma Using Granulocyte-Macrophage Colony-Stimulating Factor. Journal of Clinical Oncology. 18(8). 1614–1621. 211 indexed citations

Jacobs, Mark. (1990). Endoscopic biliary decompression aided by a different technique of percutaneous transhepatic access. Gastrointestinal Endoscopy. 36(5). 503–505. 3 indexed citations

10.

Jacobs, Mark & Ross Benger. (1989). Metastatic breast carcinoma of the orbit. Australian and New Zealand Journal of Ophthalmology. 17(4). 357–361. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact